Secretory immunoglobulin A (sIgA) plays a crucial role in mucosal surface defense. We tested the hypothesis that colonic sIgA secretion is under enteric neural control. Immunohistochemistry of the porcine distal colonic mucosa revealed presumptive cholinergic and adrenergic nerve fibers apposed to secretory component (SC)-positive crypt epithelial cells and neighboring IgA + plasmacytes. The cholinomimetic drug carbamylcholine elicited rapid, atropine-sensitive IgA secretion into the luminal fluid bathing mucosal explants mounted in Ussing chambers. The adrenergic receptor agonist norepinephrine also increased IgA secretion, an action inhibited by phentolamine. These effects were independent of agonist-induced anion secretion. In Western blots of luminal fluid, both agonists increased the density of protein bands coimmunoreactive for IgA and SC. Mucosal exposure to enterohemorrhagic Escherichia coli did not affect IgA secretion, and carbamylcholine treatment did not affect mucosal adherence of this enteropathogen. Acetylcholine and norepinephrine, acting respectively through muscarinic cholinergic and alpha-adrenergic receptors in the colonic mucosa, stimulate sIgA secretion and may enhance mucosal defense in vivo.
Introduction
Immunoglobulin A (IgA) is the most abundant immunoglobulin present at all mucosal surfaces, where it plays crucial roles in mucosal protection (Woof and Kerr, 2006) . It is produced and released as a J chain-linked dimer by resident IgA + plasma cells in mucosal tissues, including the extensive lamina propria of the intestine. Dimeric IgA is recognized by the polymeric Ig receptor (pIgR) expressed by neighboring epithelial cells, subsequently transcytosed through pIgR + cells, and enzymatically cleaved at the mucosal surface to form secretory IgA (sIgA). The higher molecular weight sIgA represents dimeric IgA covalently bound to secretory component (SC), a remnant of the polymeric Ig receptor which prevents sIgA degradation. Due to constitutive pIgR transcytosis in epithelial cells, free SC may also be secreted and appears to possess important protective functions per se (Kaetzel, 2005) . Factors that regulate the rate and magnitude of sIgA secretion are not completely defined.
Neural stimulation and various neurotransmitter substances appear to alter sIgA released by acinar cells and ductal epithelial cells in lacrimal and salivary glands (Kelleher et al., 1991; Lambert et al., 1994; Proctor and Carpenter, 2002; Teeuw et al., 2004) . Experiments with rat salivary glands, for example, indicate that sIgA secretion is regulated by sympathetic and parasympathetic nerves (Carpenter et al., 1998; Proctor et al., 2000) . The output of sIgA is also modified by injections of cholinomimetic and sympathomimetic drugs into the salivary gland blood supply (Proctor et al., 2003b) or direct application of adrenergic agonists to salivary gland cells (Carpenter et al., 2004) . Although the intestinal tract is a major site for mucosal immunity and is extensively innervated, little is known about the neural regulation of enteric sIgA secretion. The intravenous injection of cholinomimetic drugs or the gut neuropeptides cholecystokinin and substance P has been 
